Designing supramolecular therapies to cross the blood-brain barrier
A new Northwestern Medicine study has uncovered key molecular design principles that could help supramolecular therapeutics cross the blood-brain barrier, a major challenge for this novel approach to treating neurological disorders.
Next post
The first wave of bird flu is the worst: What can Australia learn from overseas?
